Filing Details

Accession Number:
0001213900-19-013085
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-18 13:31:26
Reporting Period:
2019-07-16
Accepted Time:
2019-07-18 13:31:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1176309 Oramed Pharmaceuticals Inc. ORMP Pharmaceutical Preparations (2834) 980376008
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1416089 Leonard Sank 3 Blair Road
Cape Town T3 8005
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-16 20,000 $3.47 315,482 No 4 P Direct
Common Stock Acquisiton 2019-07-17 20,000 $3.58 335,482 No 4 P Direct
Common Stock Acquisiton 2019-07-17 10,020 $3.74 345,502 No 4 P Direct
Common Stock Acquisiton 2019-07-18 4,497 $3.86 349,999 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 78,125 Indirect Via spouse
Common Stock 138,889 Indirect Via trust
Footnotes
  1. Mr. Sank disclaims beneficial ownership of these shares.
  2. These shares consist of shares of common stock owned by a company wholly owned by a trust of which Mr. Sank is a trustee. Mr. Sank disclaims beneficial ownership of these shares.